Virtual West Oncology Conference

 

Virtual West Oncology Conference
Avatar

ASH Updates on MDS: Is Luspatercept Affecting Biomarkers of Erythropoiesis in LR-IR Disease? Is EFS Better With Pevonedistat+Aza vs. Aza Alone in HR-MDS? Should We Combine Ven+Aza?

By Virtual West Oncology Conference FEATURING Jason Chandler
By Virtual West Oncology Conference FEATURING Jason Chandler
118 views
March 11, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

08:18
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…

Feat. A. Zhou

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam
Videos
25:11
Virtual West Oncology Conference

66 y/o Male With DLBCL: R-CHOP, Revlimid Upfront, Curative Options, …

Feat. J. Chandler, N. Mehta-Shah, A. Yacoub, C. Bachier
13:21
Virtual West Oncology Conference

72 y/o Female With High WBCs, Low Platelet Count & Cytopenia: Op…

Feat. J. Chandler, N. Mehta-Shah, A. Yacoub, C. Bachier
10:41
Virtual West Oncology Conference

ASH Updates on CML: Pathogenesis and Outcomes, 1L Therapy Choices, T…

Feat. A. Yacoub
15:01
Virtual West Oncology Conference

ASH Updates on MDS: Is Luspatercept Affecting Biomarkers of Erythrop…

Feat. J. Chandler
17:39
Virtual West Oncology Conference

2021 Update on Breast Cancer Brain Metastases: Current Treatment Opt…

Feat. L. Schwartzberg
22:48
Virtual West Oncology Conference

40 y/o Premenopausal Woman With HR+ eBC: What Is the Best Local Ther…

Feat. L. Schwartzberg, N. Vidula, T. Mamounas, K. Mirabeau-Beale, J. Meisel, G. Vidal
14:33
Virtual West Oncology Conference

59 y/o Woman With HER+ eBC: Neoadjuvant Chemo, Post-neoadjuvant Syst…

Feat. L. Schwartzberg, N. Vidula, T. Mamounas, K. Mirabeau-Beale, J. Meisel, G. Vidal
16:11
Virtual West Oncology Conference

Genomic Expression Panels for Chemo in eBC: Does Adjuvant Chemo Show…

Feat. T. Mamounas
16:46
Virtual West Oncology Conference

2021 Updates on mTNBC: Do Olaparib/Talazoparib Improve PFS Compared …

Feat. N. Vidula
20:35
Virtual West Oncology Conference

2021 Update on EGFR Resistant NSCLC: How Effective Are Current Optio…

Feat. S. Kazmi
06:21
Virtual West Oncology Conference

ASH Updates on CAR-T in R/R DLBCL: When to Consider? Can It Be Used …

Feat. N. Mehta-Shah
07:20
Virtual West Oncology Conference

ASH Updates on Lymphomas: Bispecific Antibodies for Patients Who Rel…

Feat. N. Mehta-Shah
07:11
Virtual West Oncology Conference

ASH Updates on Relapsed/Refractory Hodgkin Lymphomas and PTCL: What …

Feat. N. Mehta-Shah
30:58
Virtual West Oncology Conference

Non-Muscle Invasive Urothelial Carcinoma Case Disussion: 62 y/o Male…

Feat. B. Somer, D. Vaena, J. Hoffman-Censits, A. Luckenbaugh, H. Gieschen, H. Greene
18:56
Virtual West Oncology Conference

Advanced NSCLC Case Expert Discussion: Incurable Recurrent Stage 3b …

Feat. E. Massarelli, S. Kazmi, J. Porter, E. Gillaspie, K. Keane
13:35
Virtual West Oncology Conference

mNSCLC Case Expert Discussion: Left Lung SCC With Bone Metastases - …

Feat. E. Massarelli, S. Kazmi, J. Porter, E. Gillaspie, K. Keane
15:58
Virtual West Oncology Conference

2021 Updates on mNCSLC: Single Agent IO and Combination Therapy Appr…

Feat. J. Porter
15:01
Virtual West Oncology Conference

2021 Updates on NMIBC: Low-Grade vs. High-Grade pTa, pT1, Carcinoma …

Feat. A. Luckenbaugh
18:41
Virtual West Oncology Conference

2021 Updates in RCC: Surveying Data for SWOG 1500, Belzutifan, CLEAR…

Feat. B. Somer
06:49
Virtual West Oncology Conference

Targeted Therapy in ROS-1 & KRAS-Mutated Advanced NSCLC: Efficac…

Feat. E. Massarelli
16:08
Virtual West Oncology Conference

2021 Updates on RC: Does Neoadjuvant Chemo Improve Outcomes? Who Nee…

Feat. N. Vanderwalde
15:43
Virtual West Oncology Conference

2021 Update on ctDNA Analysis in Colorectal Cancer: Surveying Applic…

Feat. G. Botta
14:54
Virtual West Oncology Conference

Borderline Resectable Pancreatic Cancer Updates: What Are the Anatom…

Feat. P. Dickson
22:30
Virtual West Oncology Conference

2021 Updates on Advanced Bladder Cancer: What Agents Are Available i…

Feat. J. Hoffman-Censits
08:44
Virtual West Oncology Conference

2021 Update on ADT Intensification for mCSPC: What Are the Benefits …

Feat. D. Vaena
12:40
Virtual West Oncology Conference

2021 Highlights on PARPi for mCRPC & PSMA Imaging: What Is the E…

Feat. D. Vaena
06:27
Virtual West Oncology Conference

Targeted Therapy for RET Fusion+ NSCLC: Efficacy Data for FDA Approv…

Feat. E. Massarelli
05:28
Virtual West Oncology Conference

2021 Advanced NSCLC Targeted Therapy Updates: Efficacy & Safety …

Feat. E. Massarelli